#USA #Barcelona #UCB #Pharmacovigilance #Veeva Safety Suite

UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite

In a significant step towards enhancing operational efficiency, UCB has announced its decision to consolidate its global safety operations using the Veeva Safety Suite. This strategic move is designed to streamline pharmacovigilance processes and improve overall service delivery in patient safety. The integration will enable UCB to utilize a single unified platform, allowing for better collaboration, increased speed in case processing, and more reliable data management for safety reporting.

Transformative Benefits of Veeva Safety Suite

Jonas Maselis, the Chief Digital Technology and Patient Safety Officer at UCB, emphasized that this migration to the Veeva Safety Suite signifies a pivotal transformation in UCB's safety framework. He stated, “This transition allows us to optimize both local and global workflows through one reliable source of safety data.” Utilizing automation, UCB aims to improve the efficiency of its workflow, positioning itself favorably for future challenges.

UCB will leverage several components of Veeva Safety Suite, including tools that enhance the management of safety-related processes. For instance, Veeva Safety will facilitate the efficient handling of adverse event reporting, while Veeva SafetyDocs will manage all documents and processes linked to safety. Furthermore, Veeva Safety Workbench is set to enable advanced data analytics for faster and scalable reporting, showcasing a commitment to continuous improvement.

A notable feature of this suite is Veeva Safety Signal, which automates signal detection, offering improved visibility across UCB’s operational structures. This, in conjunction with the Veeva Safety-RIM connection, will automatically share product information among regulatory and safety functions, ensuring that UCB maintains clean, comprehensive, and trustworthy data throughout its operations.

Enhancing Compliance and Efficiency

“Incorporating Veeva Safety Suite lays the groundwork for UCB to simplify and standardize its global pharmacovigilance function,” remarked John Lawrie, Veeva Safety's Vice President. He showcased the collective impact of adopting a unified, integrated approach in improving regulatory compliance on a global scale while simultaneously boosting advanced automation. This move positions UCB to deliver medicines that are not only safe but also effective for patients.

About Veeva Systems

Veeva Systems, a renowned cloud platform provider for the life sciences industry, offers a suite of tools that caters to various consumer needs. With an unwavering focus on innovation and product excellence, Veeva services over 1,500 clients, ranging from leading pharmaceutical firms to emerging biotechnology players. As a public benefit corporation, Veeva operates with a commitment to balance the interests of all its stakeholders, ensuring sustainable growth and service delivery. For further details about their services, you can visit veeva.com/eu.

Looking Ahead

As UCB embarks on this new chapter, the integration with Veeva Safety Suite not only reflects their dedication to enhancing patient safety but also their commitment to pioneering regulatory adherence and workflow efficiency. This initiative is expected to have a significant positive impact on their operational capabilities, ultimately leading to improved healthcare outcomes for patients globally.